Vo
Volato Group
Houston TXFounded 2021200 employees
Private CapbiotechPrivateOncology
Platform: Aviation n/a
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
0
FDA Approved
2
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tezecilimab | VOL-5771 | Approved | 4 | VEGF | NB | ||
| Tezesotorasib | VOL-2361 | Phase 2/3 | 2 | DLL3 | TTR AmyloidosisProstate Ca | ||
| Gozelemzoparlimab | VOL-4978 | Approved | 1 | PI3Kα | HCC | ||
| Tezezasiran | VOL-3691 | Phase 2 | 1 | PRMT5 | MigraineADPKD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)